FIG 1.
Cumulative probability of progression among patients. The Kaplan-Meier method was used for estimation of cumulative incidence of progression (A) among patients with asymptomatic Waldenström macroglobulinemia and stratified by (B) immunoglobulin M (IgM) levels, (C) bone marrow (BM) involvement, (D) β2-microglobulin, and (E) albumin.